Birmingham, AL, November 14, 2010 --(PR.com
)-- Birmingham, Alabama— Achieve Clinical Research, a privately owned research facility, founded in 1998 in Birmingham, Alabama, announces the launch of several research studies to test investigational treatment options for those already diagnosed with influenza. "Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with influenza," says Hayes Williams, MD, PhD., the Medical Director and Principal Investigator at Achieve Clinical Research since 2001. "Treatments for influenza are one of the research studies we are pleased to continue with at Achieve Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans."
The research studies will enroll those already diagnosed with influenza, which could include symptoms like a continuous fever of 100°F to 104°F, body aches and muscle pain, headache, pain when moving eyes, fatigue, loss of appetite, dry cough, runny nose, and dry or sore throat. In order to participate in the studies volunteers must be diagnosed with influenza. Achieve Clinical Research will not take volunteers who:
·have any evidence or treatment of malignancy within the previous 5 years,
·have a history of alcohol or substance abuse within the previous 5 years,
·have used an investigatory medicine or participated in an investigatory study within 30 days of the screening,
·are pregnant, or
Achieve Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our research studies, contact Achieve Clinical Research at 205.757.8208, or at www.AchieveClinical.com.